About the Nordic Thoracic Oncology Group (NTOG)
The NTOG is a multidisciplinary network of lung cancer researchers and clinicians representing Denmark, Finland, Iceland, Norway, and Sweden. Our mission is to enhance lung cancer research and optimize patient care through strengthened collaboration across the Nordic region.
Learn MoreNordic Lung Cancer Symposium 2027
13 - 15 May 2027 | Copenhagen, Denmark
Join us for the biennial Nordic Lung Cancer Symposium, a premier gathering of lung cancer specialists from across the Nordic region. The 2027 edition focuses on advancing collaboration and innovation in thoracic oncology, with a multidisciplinary program tailored for researchers, clinicians, and healthcare professionals.
- Stage III Non-Small Cell Lung Cancer (NSCLC): In-depth discussions on emerging treatments, case studies, and interdisciplinary approaches.
- Lung Cancer Screening: Updates on screening pilots and nodule management.
- Nordic Lung Cancer Registries: Do lung cancer quality indicators make a difference?
Research and Collaboration
NTOG supports Nordic collaboration in clinical, registry-based, and translational lung cancer research. By connecting expertise and data across the Nordic countries, we aim to strengthen research quality, compare outcomes, identify best practices, and improve care for patients with thoracic cancers.
Subtopics:
- Nordic lung cancer registries and quality indicators
- Multidisciplinary team models and care pathways
- Lung cancer screening and early detection
- Stage III NSCLC treatment strategies
- Clinical trial collaboration
- Translational research and biomarker studies
Join NTOG
Physicians and researchers based in the Nordic countries and involved in thoracic oncology research or clinical care are welcome to join NTOG. Membership is free and provides access to a network of professionals dedicated to improving lung cancer outcomes.
Join the NTOG LinkedIn group